Delivery Order SPE2DB22D1017-SPE2DB25FG1VD

Award Date 5/5/25
Potential Completion Date 5/27/25
Potential Value $9.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 contract is for the supply of 4,567,998,903 units of the prescription medication Venclexta 100 mg tablets. The award has an ultimate completion date of May 13, 2025 and is not set aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Venclexta 100 mg tablets. The contract has a ceiling value of $9,728.17 and a period of performance through May 23, 2025. This order is not set aside and is a firm fixed-price, delivery order contract. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $8,880.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 4,565,266,344 units of the prescription drug VENCLEXTA 100 mg tablets. The contract has an ultimate completion date of August 16, 2024 and was awarded on July 26, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 firm fixed-price contract is for the delivery of 4,567,503,935 units of the drug Venclexta 100 mg tablets. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Venclexta 50 mg tablets, a specialty medication. The contract has a ceiling value of $1,092.52 and an ultimate completion date of January 22, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Venclexta 100 mg tablets, a prescription medication. The contract has a ceiling value of $9,728.17 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Venclexta 100 mg tablets, a specialty medication used to treat chronic lymphocytic leukemia. The contract has a ceiling value of $9,187.06 and a period of performance through January 8, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a $17,760.30 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA). The contract is for the supply of 4,564,816,489 tablets of the prescription drug Venclexta 100 mg, which is used to treat chronic lymphocytic leukemia. The contract has a period of performance through June 27, 2024 and does not include a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Venclexta 100 mg tablets. The contract has a ceiling value of $8,880.15 and runs through January 30, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. The contract is a firm fixed-price delivery order issued under a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,597.26, is for the delivery of the prescription medication Venclexta 100 mg tablet (28 count) through December 30, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG1VD
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,140,312 units of the prescription medication Venclexta 100 mg tablets. The contract has a ceiling value of $9,728.17 and a performance period ending on May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with AmerisourceBergen, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the DLA, Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026. The contract is not set-aside and represents open competition. This award demonstrates AmerisourceBergen's role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/4/25, 9:53 AM